Founders at Work Seminar: Redefining Brain Disease Treatment with Olfactory Prodrugs
March 29 @ noon - 1pm
135 Mississippi St, San Francisco
Come hear from our new resident company at 135 Mississippi, Olfera Therapeutics at our upcoming Founders at Work seminar. Open to the public.
For many promising neurological drugs, the blood-brain barrier presents a significant hurdle to reaching their target. Olfera employs a distinctive alternative: the nose-to-brain delivery pathway. Tapping into the olfactory epithelium's natural abilities, Olfera’s platform leverages a novel chemistry prodrug strategy and innovative technology to enable efficient and targeted intranasal delivery of neurological drugs to the brain. This approach holds the potential to revolutionize brain disease treatments by improving drug efficacy and patient outcomes.
► REGISTER
|